Agenda Coming Soon.

LL&M Winter Symposium offers a concentrated, early-year program focused on quickly integrating the most recent global research and clinical trial data into real-world practice.

At the 2027 meeting, you will engage with concise, data-driven sessions spanning leukemia, lymphoma, myeloma, and CLL—featuring insights synthesized directly from the latest data presented at 2026’s major hematology meetings, recent data releases, and new regulatory approvals. You can expect timely updates on critical topics such as resistance to targeted therapies, evolving combination strategies, the growing role of MRD in guiding treatment decisions, and the expanding use of cellular therapies and bispecific antibodies. The program will also address frontline and relapsed/refractory treatment approaches, transplant decision-making, and emerging therapeutic strategies across disease states.

Sessions will feature rapid, 20-minute updates paired with expert-led, case-based discussions, giving you practical insight into how new data applies in everyday clinical settings. Interactive panels will further deepen learning, helping you navigate complex patient scenarios and make more informed treatment decisions.

Join leading experts as they break down the latest evidence—and what it means for your practice.

Stay tuned for the full 2027 agenda.